Form 4 for STRO SUTRO BIOPHARMA, INC.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-12-01 · accession 0001415889-24-028066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-03 | 2024-12-01 | STRO | Chung Jane | Pres AND COO | F - Tax | $2.69 | -8,920 | 70.3K | -11% | -$24.0K |
| D | 2024-12-03 | 2024-12-01 | STRO | Chung Jane | Pres AND COO | M - OptEx | $0.00 | +25.0K | 79.3K | +46% | $0 |
| D | 2024-12-03 | 2024-12-01 | STRO | Chung Jane | Pres AND COO | M - OptEx | $0.00 | -25.0K | 75.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-01 | F | D | 8,920 | $2.69 | 70,342 | D | — | — | (F1) Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person. |
| 2 | Common | Common Stock | 2024-12-01 | M | A | 25,000 | $0.00 | 79,262 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit (RSU) | 2024-12-01 | M | D | 25,000 | $0.00 | 75,000 | D | — · — to 2027-12-01 | 25,000 Common Stock | (F2) Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. (F3) The RSUs vest as to 1/4th of the total shares annually beginning on December 1, 2024, subject to continued service through each vesting date. |